Cellectar Biosciences Inc.

(CLRB) Trade

By |

Profile

Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.

Contact Information

Website: www.cellectar.com
Email: epiros@rodmanandrenshaw.com
Main Phone: +1 608 441-8120
Address: 3301 Agriculture Drive
State: WI
City / Town: Madison
Country: USA
Postal Code: 53716

Issuer Information

Exchange: NSC
CEO: James V. Caruso
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.68 $ -0.02 (-0.74%)
Last Price 2.68 Change $ -0.02 Change % -0.74 Tick N/A
Bid 2.70 Bid Size 1,800.00 Ask 3.00 Ask Size 100.00
Open 2.68 High 2.70 Low 2.52 Prev Close 2.70
Last Trade Volume 119,340 52 Wk Hi 20.40 52 Wk Low 2.03
Market Cap 10.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 3,797,825.00 EPS (TTM) -9.79 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 3
Number of Buys 0 0
Number of Sells 0 3
Net Activity 0 -52214
Last 10 Buys Shares
John P. Neis 1,000
John P. Neis 1,000
Stephen A. Hill 1,000
Paul L. Berns 1,000
James V. Caruso 1,000
James V. Caruso 1,000
James V. Caruso 1,000
James V. Caruso 1,000
James V. Caruso 1,000
Marxe W Austin 1,000
Last 10 Sell Shares
Jarrod Longcor 1,000
James V. Caruso 1,000
John P. Neis 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.1 3.1 3.1 3.1
Low Target Price Estimate 3.1 3.1 3.1 3.1
Mean Target Price Estimate 3.1 3.1 3.1 3.1
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/25/18 05/25/18 04/02/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1